Impact of α-lipoic acid on liver peroxisome proliferator-activated receptor-α, vascular remodeling, and oxidative stress in insulinresistant rats

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 10, 2011, Pages 743-751

  El Midaoui, Adil ^a   Lungu, Calin ^a   Wang, Hui ^b   Wu, Lingyun ^b   Robillard, Caroline ^a   Deblois, Denis ^a   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

A lipoic acid; Hypertension; Insulin resistance; Liver; Oxidative stress; PPAR ; Vascular remodeling

Indexed keywords

BETA ACTIN; FATTY ACID; GLUCOSE; INSULIN; LUCIGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SUPEROXIDE; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTICLE; CARDIOVASCULAR SYSTEM; CHEMOLUMINESCENCE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; MALE; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ANIMALS; AORTA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; DIETARY SUPPLEMENTS; FATTY ACIDS, NONESTERIFIED; FOOD, FORTIFIED; GLUCOSE; INSULIN; INSULIN RESISTANCE; LIVER; MALE; OXIDATIVE STRESS; PPAR ALPHA; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; THIOCTIC ACID;

EID: 80053087465     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-072     Document Type: Article

References (40)

1. Carretero, O.A., and Oparil, S. 2000. Essential hypertension: part II: treatment. Circulation, 101(4): 446-453. PMID:10653838.
2. Chen, X.F., Wang, J.-A., Lin, X.-F., Tang, L.-J., Yu, W.-F., Chen, H., et al. 2009. Diabetes mellitus: Is it protective against aortic root dilatation? Cardiology, 112(2): 138-143. doi:10.1159/000142944. PMID:18600023.
3. Desvergne, B., and Wahli, W. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20(5): 649-688. doi:10.1210/er.20.5.649. PMID:10529898.
4. Diep, Q.N., Amiri, F., Touyz, R.M., Cohn, J.S., Endemann, D., Neves, M.F., and Schiffrin, E.L. 2002. PPAR-alpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension, 40(6): 866-871. doi:10.1161/01.HYP. 0000037969.41360.CC. PMID:12468571.
5. Du, X., Jiang, Y., Qian, W., Lu, X., and Walsh, J.P. 2001. Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells. Biochem. J. 357(1): 275-282. doi:10.1042/0264-6021:3570275. PMID:11415460.
6. El Midaoui, A., and de Champlain, J. 2002. Prevention of hypertension, insulin resistance, and oxidative stress by alphalipoic acid. Hypertension, 39(2): 303-307. doi:10.1161/hy0202. 104345. PMID:11847202.
7. El Midaoui, A., Ongali, B., Petcu, M., Rodi, D., de Champlain, J., Neugebauer, W., and Couture, R. 2005. Increases of spinal kinin receptor binding sites in two rat models of insulin resistance. Peptides, 26(8): 1323-1330. doi:10.1016/j.peptides.2005.03.028. PMID:16042974.
8. El Midaoui, A., Wu, L., Wang, R., and de Champlain, J. 2006. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-g expression by oxidative stress in chronically glucose-fed rats. Am. J. Hypertens. 19(4): 407-412. doi:10.1016/j.amjhyper. 2005.11.006. PMID:16580578.
9. Farasat, S.M., Morrell, C.H., Scuteri, A., Ting, C.-T., Yin, F.C., Spurgeon, H.A., et al. 2008. Pulse Pressure is inversely related to aortic root diameter implications for the pathogenesis of systolic hypertension. Hypertension, 51(2): 196-202. doi:10.1161/ HYPERTENSIONAHA.107.099515. PMID:18158348.
10. Fiordaliso, F., Cuccovillo, I., Bianchi, R., Bai, A., Doni, M., Salio, M., et al. 2006. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes. Life Sci. 79(2): 121-129. doi:10.1016/j.lfs.2005.12.036. PMID: 16445948.
11. Ginsberg, H.N. 2000. Insulin resistance and cardiovascular disease. J. Clin. Invest. 106(4): 453-458. doi:10.1172/JCI10762. PMID: 10953019.
12. Guan, Y. 2004. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J. Am. Soc. Nephrol. 15(11): 2801-2815. doi:10.1097/01.ASN. 0000139067.83419.46. PMID:15504933.
13. Gundersen, H.J.G., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., et al. 1988. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Acta Pathol. Microbiol. Scand. (APMIS), 96(10): 857-881. doi:10.1111/j. 1699-0463.1988.tb00954.x. PMID:3056461.
14. Inoguchi, T., Li, P., Umeda, F., Yu, H.Y., Kakimoto, M., Imamura, M., et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C- dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 49(11): 1939-1945. doi:10.2337/diabetes.49.11. 1939. PMID:11078463.
15. Kim, S.K., Zhao, Z.S., Lee, Y.J., Lee, K.E., Kang, S.M., Choi, D., et al. 2003. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-α or -γ agonists in a type 2 diabetic animal model. Diabetes Metab. Res. Rev. 19(6): 487-493. doi:10.1002/dmrr.410. PMID:14648808.
16. Kim, M.-S., Park, J.-Y., Namkoong, C., Jang, P.-G., Ryu, J.-W., Song, H.-S., et al. 2004. Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nat. Med. 10(7): 727-733. doi:10.1038/nm1061. PMID: 15195087.
17. Koh, E.H., Kim, M.S., Park, J.Y., Kim, H.S., Youn, J.Y., Park, H.S., et al. 2003. Peroxisome proliferator-activated receptor (PPAR)- alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation. Diabetes, 52(9): 2331-2337. doi:10. 2337/diabetes.52.9.2331. PMID:12941773.
18. Lungu, C., Dias, J.P., Estevao de França, C., Ongali, B., Regoli, D., Moldovan, F., and Couture, R. 2007. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance. Neuropeptides, 41(6): 375-387. PMID:17988733.
19. Marx, N., Duez, H., Fruchart, J.C., and Staels, B. 2004. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ. Res. 94(9): 1168-1178. doi:10.1161/01.RES.0000127122.22685.0A. PMID:15142970.
20. Mitchell, G.F., Conlin, P.R., Dunlap, M.E., Lacourcière, Y., Arnold, J.M., Ogilvie, R.I., et al. 2008. Aortic diameter, wall stiffness, and wave reflection in systolic hypertension. Hypertension, 51(1): 105-111. doi:10.1161/HYPERTENSIONAHA.107.099721. PMID:18071054.
21. Mulvany, M.J. 2003. Structural abnormalities of the resistance vasculature in hypertension. J. Vasc. Res. 40(6): 558-560. doi:10.1159/000075805. PMID:14691337.
22. Münzel, T., Sayegh, H., Freeman, B.A., Tarpey, M.M., and Harrison, D.G. 1995. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95(1): 187-194. doi:10.1172/JCI117637. PMID:7814613.
23. Ohara, Y., Peterson, T.E., and Harrison, D.G. 1993. Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91(6): 2546-2551. doi:10.1172/JCI116491. PMID: 8390482.
24. Olefsky, J.M. 2000. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J. Clin. Invest. 106 (4): 467-472. doi:10.1172/JCI10843. PMID:10953021.
25. Packer, L., Kraemer, K., and Rimbach, G. 2001. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition, 17(10): 888-895. doi:10.1016/S0899-9007(01)00658-X. PMID: 11684397.
26. Saltiel, A.R., and Olefsky, J.M. 1996. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes, 45(12): 1661-1669. doi:10.2337/diabetes.45.12.1661. PMID:8922349.
27. Seedorf, U., and Assmann, G. 2001. The role of PPAR alpha in obesity. Nutr. Metab. Cardiovasc. Dis. 11(3): 189-194. PMID: 11590995.
28. Sena, C.M., Nunes, E., Louro, T., Proença, T., Fernandes, R., Boarder, M.R., and Seiça, R.M. 2008. Effects of alpha-lipoic acid on endothelial function in aged diabetic and high-fat fed rats. Br. J. Pharmacol. 153(5): 894-906. doi:10.1038/sj.bjp.0707474. PMID: 17906683.
29. Smith, A.R., Visioli, F., Frei, B., and Hagen, T.M. 2008. Lipoic acid significantly restores, in rats, the age-related decline in vasomotion. Br. J. Pharmacol. 153(8): 1615-1622. doi:10.1038/bjp.2008. 28. PMID:18297110.
30. Stepniakowski, K.T., Goodfriend, T.L., and Egan, B.M. 1995. Fatty acids enhance vascular alpha-adrenergic sensitivity. Hypertension, 25(4 Pt 2): 774-778. PMID:7721431.
31. Stepp, D.W., Pollock, D.M., and Frisbee, J.C. 2004. Low-flow vascular remodeling in the metabolic syndrome X. Am. J. Physiol. Heart Circ. Physiol. 286(3): H964-H970. doi:10.1152/ajpheart. 00836.2003. PMID:14644764.
32. Streeper, R.S., Henriksen, E.J., Jacob, S., Hokama, J.Y., Fogt, D.L., and Tritschler, H.J. 1997. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am. J. Physiol. 273(1 Pt 1): E185-E191. PMID:9252495.
33. Struijker-Boudier, H.A., van Essen, H., Fazzi, G., De Mey, J.G., Qiu, H.Y., and Lévy, B.I. 1996. Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats. Hypertension, 28(5): 779-784. PMID:8901823.
34. Tontonoz, P., Hu, E., and Spiegelman, B.M. 1994. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell, 79(7): 1147-1156. doi:10.1016/0092-8674(94)90006-X. PMID:8001151.
35. Vranes, D., Cooper, M.E., and Dilley, R.J. 1999. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc. Res. 57(1): 8-18. doi:10.1006/mvre.1998.2107. PMID:9882558.
36. Wu, L., and de Champlain, J. 1999. Superoxide anion-induced formation of inositol phosphates involves tyrosine kinase activation in smooth muscle cells from rat mesenteric artery. Biochem. Biophys. Res. Commun. 259(2): 239-243. doi:10.1006/bbrc.1999. 0762. PMID:10362493.
37. Wu, R., Laplante, M.A., and De Champlain, J. 2004. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats. J. Hypertens. 22 (4): 793-801. doi:10.1097/00004872-200404000-00023. PMID: 15126922.
38. Xiang, G.D., Sun, H.L., Zhao, L.S., Hou, J., Yue, L., and Xu, L. 2008. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycemia during OGTT in impaired glucose tolerance. Clin. Endocrinol. (Oxf.), 68(5): 716-723. doi:10.1111/j.1365-2265.2007.03099.x. PMID:18070144.
39. Zieman, S.J., Melenovsky, V., and Kass, D.A. 2005. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 25(5): 932-943. doi:10.1161/01.ATV. 0000160548.78317.29. PMID:15731494.
40. Åstrand, H., Rydén-Ahlgren, A., Sundkvist, G., Sandgren, T., and Lanne, T. 2007. Reduced aortic wall stress in diabetes mellitus. Eur. J. Vasc. Endovasc. Surg. 33(5): 592-598. doi:10.1016/j.ejvs. 2006.11.011. PMID:17164093.